SHERRY LEROY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PENSACOLA, FL NPI 1548869142
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$2,685.75
- Category: General Payments
- Program years: PY2021–2024
- Record count: 102
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $550.61 across 25 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $550.61 | 25 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $141.86 | 7 |
| EISAI INC. | $55.54 | 2 |
| Mirati Therapeutics, Inc. | $46.03 | 1 |
| E.R. Squibb & Sons, L.L.C. | $39.50 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $27.73 | 1 |
| GENZYME CORPORATION | $27.54 | 1 |
| ARRAY BIOPHARMA INC | $24.12 | 1 |
| Pharmacosmos Therapeutics Inc. | $23.17 | 1 |
| Merck Sharp & Dohme Corporation | $20.70 | 1 |
| Adaptive Biotechnologies Corporation | $17.67 | 1 |
| Celgene Corporation | $17.39 | 1 |
| PFIZER INC. | $17.35 | 1 |
| Genmab U.S., Inc. | $16.68 | 1 |
| SpringWorks Therapeutics, Inc. | $16.06 | 1 |
| Astellas Pharma US Inc | $15.10 | 1 |
| Coherus Biosciences Inc. | $13.19 | 1 |
By program year
Records — PY2024 (25)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.